Your browser doesn't support javascript.
loading
Multiplex Tissue Imaging Harmonization: A Multicenter Experience from CIMAC-CIDC Immuno-Oncology Biomarkers Network.
Akturk, Guray; Parra, Edwin R; Gjini, Evisa; Lako, Ana; Lee, J Jack; Neuberg, Donna; Zhang, Jiexin; Yao, Shen; Laface, Ilaria; Rogic, Anita; Chen, Pei-Hsuan; Sanchez-Espiridion, Beatriz; Valle, Diane M Del; Moravec, Radim; Kinders, Robert; Hudgens, Courtney; Wu, Catherine; Wistuba, Ignacio I; Thurin, Magdalena; Hewitt, Stephen M; Rodig, Scott; Gnjatic, Sacha; Tetzlaff, Michael T.
Afiliação
  • Akturk G; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Parra ER; Translational Molecular Pathology-Dermatopathology Laboratory, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gjini E; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Lako A; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Lee JJ; Translational Molecular Pathology-Dermatopathology Laboratory, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Neuberg D; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Zhang J; Translational Molecular Pathology-Dermatopathology Laboratory, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Yao S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Laface I; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Rogic A; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Chen PH; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Sanchez-Espiridion B; Translational Molecular Pathology-Dermatopathology Laboratory, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Valle DMD; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Moravec R; Kelly Services; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, Maryland.
  • Kinders R; Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Hudgens C; Translational Molecular Pathology-Dermatopathology Laboratory, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wu C; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Wistuba II; Translational Molecular Pathology-Dermatopathology Laboratory, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Thurin M; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, Maryland.
  • Hewitt SM; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Rodig S; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Gnjatic S; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Tetzlaff MT; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
Clin Cancer Res ; 27(18): 5072-5083, 2021 09 15.
Article em En | MEDLINE | ID: mdl-34253580
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article